4DMedicalASX:4DX -7.24%64 Receivables Turnover is 2.22 as of Dec. 2025. GuruFocus rates ASX:4DX with a GF Score™ of 64/100 and a GF Value™ of A$1.45 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 811 Medical Devices & Instruments companies, 4DMedical ranks worse than 64.12% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. 4DMedical's Revenue for the
six
months ended in Dec. 2025 was A$2.80 Mil. 4DMedical's average Accounts Receivable for the
six
months ended in Dec. 2025 was A$1.26 Mil.
Hence, 4DMedical's Receivables Turnover for the
six
months ended in Dec. 2025 was 2.22.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
4DMedical Receivables Turnover Related Terms
4DMedical Receivables Turnover Historical Data
* Premium members only.
The historical data trend for 4DMedical's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:4DX vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, 4DMedical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4DMedical Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where 4DMedical's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4DMedical (ASX:4DX) has a Receivables Turnover of 2.22 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on 4DMedical and its competitors. According to the industry distribution chart, 4DMedical ranks #520 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 64.1%.
Is 4DMedical's Receivables Turnover too high?
4DMedical's current Receivables Turnover is 2.22. The Medical Devices & Instruments industry median Receivables Turnover is 5.55. 4DMedical's value of 2.22 is 60% below this industry median. Based on the distribution chart, 4DMedical ranks #520 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, 4DMedical has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 4DMedical ranks #520 out of 811 companies for Receivables Turnover. This places 4DMedical in the lower half of its industry. The industry median Receivables Turnover is 5.55. 4DMedical's value of 2.22 is 60% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.55, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 4DMedical's current Receivables Turnover of 2.22 is 60% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on 4DMedical and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4DMedical's current Receivables Turnover is 2.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (ASX:4DX) is currently considered Significantly Overvalued. The stock's GF Value™ is A$1.45, compared to a current price of A$4.10 — trading 182.8% above its estimated fair value. The current Receivables Turnover is 2.22 and 60% below the Medical Devices & Instruments industry median of 5.55. 4DMedical's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For 4DMedical (ASX:4DX), the current Receivables Turnover is 2.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 4DMedical (ASX:4DX) Overvalued in 2026?
Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued.
The current stock price of A$4.10 is trading 182.8% above its estimated GF Value™ of A$1.45.
GuruFocus considers 4DMedical to be Significantly Overvalued.
Key valuation signals for ASX:4DX:
Receivables Turnover: 2.22
GF Value™: A$1.45 vs. price of A$4.10 (182.8% above fair value)
Industry Position: 60% below the Medical Devices & Instruments median (#520 of 811)
No single metric tells the full story. See the ASX:4DX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
64GF Score
Get the complete analysis for ASX:4DX
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:4DX has been successfully added to your 
